Sarah Libring
Impact in
-
- MicroRNA in disease regulation
-
- Cell Adhesion Molecules Research
Papers in
-
- Angiogenesis and VEGF in Cancer 2
- Oncology 8
- Cancer Cells and Metastasis 6
- Co-authors
- Luis Solorio (13 shared papers)Michael K. Wendt (9 shared papers)Aparna Shinde (5 shared papers)Ammara Abdullah (3 shared papers)Sebastian Juan Paez (3 shared papers)Aktan Alpsoy (1 shared paper)James A. Schaber (1 shared paper)Cynthia A. Reinhart‐King (4 shared papers)
- Journals
- Cancers (3 papers)Oncogene (2 papers)Biology of the Cell (1 paper)Advanced Functional Materials (1 paper)Oncogenesis (1 paper)
- Partner nations
- United States
In The Last Decade
Sarah Libring
18 papers receiving 471 citations
Peers
Comparison fields: 5 of 70
- Cancer Research 94
- Immunology and Allergy 32
- Oncology 130
- Cell Biology 75
- Molecular Biology 234
Countries citing papers authored by Sarah Libring
This map shows the geographic impact of Sarah Libring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Libring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Libring more than expected).
Fields of papers citing papers by Sarah Libring
This network shows the impact of papers produced by Sarah Libring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Libring. The network helps show where Sarah Libring may publish in the future.
Co-authors
The 25 scholars most cited alongside Sarah Libring, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 101 | |
| 2 | 2018 | 85 | |
| 3 | 2020 | 78 | |
| 4 | 2020 | 43 | |
| 5 | 2023 | 38 | |
| 6 | 2020 | 30 | |
| 7 | 2020 | 26 | |
| 8 | 2020 | 13 | |
| 9 | 2017 | 12 | |
| 10 | 2022 | 11 | |
| 11 | 2020 | 7 | |
| 12 | 2024 | 6 | |
| 13 | 2022 | 6 | |
| 14 | 2023 | 5 | |
| 15 | 2021 | 4 | |
| 16 | 2021 | 4 | |
| 17 | 2021 | 3 | |
| 18 | 2025 | 2 |
About Sarah Libring
Sarah Libring is a scholar working on Molecular Biology, Oncology, Cell Biology, Pulmonary and Respiratory Medicine and Immunology and Allergy, having authored 18 papers that have together received 474 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (6 papers), Cellular Mechanics and Interactions (6 papers), Cell Adhesion Molecules Research (3 papers), 3D Printing in Biomedical Research (3 papers), Microfluidic and Bio-sensing Technologies (2 papers), Axon Guidance and Neuronal Signaling (2 papers), Angiogenesis and VEGF in Cancer (2 papers) and Blood properties and coagulation (2 papers). The work is most often cited by research in Cancer Research (94 citations), Immunology and Allergy (32 citations), Oncology (130 citations), Cell Biology (75 citations) and Molecular Biology (234 citations). Sarah Libring has collaborated with scholars based in United States. Frequent co-authors include Luis Solorio, Michael K. Wendt, Aparna Shinde, Ammara Abdullah, Sebastian Juan Paez, Aktan Alpsoy, James A. Schaber, Cynthia A. Reinhart‐King, Sarah Calve and Tamara L. Kinzer‐Ursem. Their work appears in journals such as Cancers, Oncogene, Biology of the Cell, Advanced Functional Materials and Oncogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.